uteinizing hormone (LH) supports steroidogenesis and maintains testicular and ovarian function (1). Mediators of LH action exert homologous regulation of receptors, steroidogenic enzymes, and other genes of the Leydig cell. In contrast to the physiological concentrations of gonadotropins that maintain steroidogenesis and gonadal LH͞human chorionic gonadotropin (hCG) and prolactin receptors, high exogenous concentrations of hCG down-regulate receptors and steroidogenic enzymes of Leydig cells at steps beyond pregnenolone formation (2-7). The impairment of steroidogenesis that follows the initial receptormediated activation is independent of receptor down-regulation and results from changes at the transcriptional levels that cause a marked reduction of enzyme expression. Recently, we cloned a gonadotropin-regulated testicular RNA helicase that is present in Leydig cells and meiotic germinal cells of the testis (8). This protein was found to be markedly up-regulated by hCG by means of cAMP-induced androgen formation in Leydig cells at hCG doses that cause down-regulation of steroidogenic enzymes and receptors.
L
uteinizing hormone (LH) supports steroidogenesis and maintains testicular and ovarian function (1) . Mediators of LH action exert homologous regulation of receptors, steroidogenic enzymes, and other genes of the Leydig cell. In contrast to the physiological concentrations of gonadotropins that maintain steroidogenesis and gonadal LH͞human chorionic gonadotropin (hCG) and prolactin receptors, high exogenous concentrations of hCG down-regulate receptors and steroidogenic enzymes of Leydig cells at steps beyond pregnenolone formation (2) (3) (4) (5) (6) (7) . The impairment of steroidogenesis that follows the initial receptormediated activation is independent of receptor down-regulation and results from changes at the transcriptional levels that cause a marked reduction of enzyme expression. Recently, we cloned a gonadotropin-regulated testicular RNA helicase that is present in Leydig cells and meiotic germinal cells of the testis (8) . This protein was found to be markedly up-regulated by hCG by means of cAMP-induced androgen formation in Leydig cells at hCG doses that cause down-regulation of steroidogenic enzymes and receptors.
In a further search for genes regulated by gonadotropin, we have isolated a previously uncharacterized protein that is downregulated by hCG and is termed gonadotropin-regulated long chain acyl-CoA synthetase (GR-LACS). This member of the LACS family is highly abundant in the Leydig cell and is distinct from the previously characterized mammalian forms of the enzyme (9) (10) (11) (12) (13) . Its constitutive expression in Leydig cells is negatively regulated by the receptor-mediated action of LH. In addition to its potential contributions to energy production and testicular steroidogenesis, GR-LACS could provide long chain acyl-CoA esters with regulatory effects on enzyme activity, membrane function, and gene expression.
Materials and Methods
Animal Treatment and Cell Preparation. The gonadotropin-induced down-regulation of LH receptor and steroidogenic enzymes in Leydig cells was produced as described (3) by administration of an s.c. injection of 2.5 g of hCG to adult male rats. Animals were killed at various times after treatment, and the testes were removed. Leydig cells were prepared by collagenase dispersion and purified by centrifugal elutriation (14) . The seminiferous tubules were minced, and the germ cells were collected by centrifugation. Cells were processed for RNA and protein analysis. (17) . Testes were fixed in 4% (vol͞vol) paraformaldehyde for 16 h at 22°C. Slides were hybridized to 35 S-labeled GR-LACS cRNA (nucleotides 824-2689) probes (sense and antisense) for 16 h at 45°C and processed as described (8) .
Western Blot and Immunocytochemistry Analysis. Western blot and immunocytochemical analyses were performed by using a rabbit polyclonal antibody raised to a GR-LACS peptide (amino acids [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] . Immunosignals were detected by using an enhanced Chemiluminescent system (Amersham Pharmacia). GR-LACS values were normalized by the corresponding ␤-actin signals. For immunolocalization of GR-LACS, testes from adult rats were fixed in 4% (vol͞vol) paraformaldehyde and embedded in paraffin. Serial sections were used for immunostaining with a peroxidase-labeled avidin-biotin detection system (18) .
Subcellular Localization of Rat GR-LACS in Mouse Leydig Tumor Cells
(mLTC) and COS-1 Cells by Using Confocal Microscopy. The full length of the GR-LACS cDNA-coding region subcloned into the pEGFP-N2 vector [GR-LACS-green fluorescent protein (GFP)] or pGFP vector only (2 g͞ml) was transfected into cells with Lipofectamine Plus (GIBCO͞BRL). After a 24-h incubation, the cells were examined in an inverted microscope or harvested for Western blot analyses by using a GFP monoclonal antibody (CLONTECH).
In Vitro Transcription͞Translation of GR-LACS cDNA. The full length of GR-LACS cDNA (1 g) in pBK CMV vector (pBK-GR-LACS) was transcribed and translated in vitro into protein with a Reticulocyte Lysate System (Promega). The empty vector (pBK) was used as the negative control. The 35 S-labeled translated protein samples were resolved on 10% SDS polyacrylamide gels.
Analysis of Fatty Acyl-CoA Synthetase (FACS) Activity. COS-1 cells were transfected with pBK-GR-LACS or pBK. FACS activities were determined in cell extracts as described (19) by using the following radiolabeled fatty acids: [ 
Results
Identification, Isolation, and Cloning of a Gonadotropin DownRegulated Expression Protein. Genes regulated by gonadotropin were obtained by the analysis of differential display patterns of RNA obtained from Leydig cells of rats treated with a single desensitizing dose of hCG (2.5 g) or of vehicle alone 24 h before killing (8) . PCR amplifications using primers 5Ј-dT11GC-3Ј and 5Ј-CTGCTTGATG-3Ј revealed a 98-bp fragment downregulated by hCG ( Fig. 1 Upper Left). RNase protection assays using the 345-bp fragment derived from the coding region of GR-LACS as a probe confirmed that this gene was downregulated by hCG in testicular Leydig cells ( Fig. 1 Upper Center). The protected fragment of ␤-actin mRNA (270 bp) showed no change.
To isolate the cDNA sequence of this hCG regulated mRNA, the 32 P-labeled 3Ј-untranslated region PCR fragment was used as a probe to screen a rat Leydig cell cDNA library. The full-length cDNA sequence of 2,689 bp contained an ORF encoding 721 amino acids (Fig. 1 Lower; accession no. AF208125). The size of the nucleotide sequence is consistent with the transcript size (2.7 kb) revealed by Northern blot analysis (Fig. 2) . The in vitro transcribed͞translated recombinant full-length cDNA of GR-LACS yielded a protein of 79 kDa ( Fig.  1 Upper Right), which was in agreement with the expected size from the deduced amino acid sequence.
A domain search of GR-LACS protein with the PROSITE program revealed a putative AMP-binding domain signature (amino acids 276-287). Also, it contained 4 potential Nglycosylation sites, a cAMP͞cGMP-dependent protein kinase phosphorylation site, 10 protein kinase C phosphorylation sites, 11 casein kinase II phosphorylation sites, 1 tyrosine kinase phosphorylation site, and 2 potential mRNA destabilizing signals ( Fig. 1 Lower) . A database search with the FASTA software (GCG) revealed an overall amino acid identity of 23-28% with LACSs of several species (9, 10, 12, 13, (20) (21) (22) (23) . A PILEUP comparison revealed that GR-LACS contains two regions that are highly conserved in LACSs and luciferases from different species. The most conserved region corresponds to amino acids 276-288 ''LxxTSGTTGNPKG'' and contains a putative AMPbinding domain. The second conserved region (amino acids 540-564) contains the FACS signature motif (24) of 25 amino acids with the 8 highly conserved amino acid residues (amino acids 540-547). Also, a neighboring sequence with conserved glycine residues in the adjacent region (GExxxxGxxxxxGY, amino acids 513-526) was found in GR-LACS as in other members of this superfamily.
Chromosomal Localization of GR-LACS. Chromosomal mapping with human, mouse, and rat lymphocytes demonstrated that this gene resides in chromosomes 8q22-24 of rat, 9BD of mouse, and 15q23-24 of human (not shown).
Tissue Distribution of GR-LACS mRNA. Northern blot analysis detected a single transcript of 2.7 kb in testis, ovary, and brain but not in uterus and the other tissues examined (Fig. 2 A Left) . The abundance of GR-LACS mRNA was relatively higher in testis than in other tissues. GR-LACS mRNA was predominantly expressed in Leydig cells and, to a lesser extent, in germ cells of adult testis. hCG-induced down-regulation of GR-LACS mRNA was observed only in Leydig cells where LH͞hCG receptors are present but not in germ cells (Fig. 2 A Right) . Western blot analysis with a specific polyclonal antibody revealed the presence of GR-LACS protein in Leydig cells, but not in testicular tubule cells or in other tissues. The antibody also detected the expressed GR-LACS-GFP fusion protein in transiently transfected COS-1 cells (Fig. 2B) .
Cellular Localization of GR-LACS mRNA and Protein Expression in
Testis. Cellular localization of GR-LACS mRNA within the rat testicular compartments (Fig. 3 A-D) revealed that GR-LACS transcripts were present predominantly in Leydig cells and more sparsely in the tubular compartment. Most of the interstitial cells showed strong signals in 46-day-old animals ( Fig. 3 C and D) and less intensity in 30-day-old animals ( Fig. 3 A and B) . Within the seminiferous tubules, labeling was observed primarily in spermatogonia but also in spermatocytes and Sertoli cells. The immunohistochemistry study revealed that GR-LACS protein was present in interstitial cells of the testis, whereas it was minimally detected in the tubules (Fig. 3 E-H) .
Gonadotropin Induced Down-Regulation of GR-LACS Gene Expression.
Further studies were conducted to gain insights into the characteristics of the regulatory mechanism(s) of hCG-mediated GR-LACS mRNA down-regulation. Only the high dose of hCG (2.5 g) induced a marked down-regulation of GR-LACS mRNA (Fig. 4A ). This desensitizing dose was used in the time course shown in Fig. 4B . No significant changes in GR-LACS mRNA levels were observed at 1 and 4 h, whereas these levels were significantly reduced at 12 h, reached maximum depression at 24 h, and returned to control levels 9 days after hCG treatment. Western blot analyses showed initial down-regulation of rat Leydig cell GR-LACS protein at 12 h (82% Ϯ 4% of control) with a further decrease at 24 h (63% Ϯ 3% of control) after treatment. Complete recovery was observed at 4 days after hCG treatment at the time when mRNA expression began to recover (Fig. 4C) . To explore whether the decrease of GR-LACS mRNA induced by hCG was related to changes in mRNA stability, we assessed GR-LACS mRNA degradation rates. The half-life of GR-LACS mRNA in the hCG-treated group was 6.5 h; in the nontreated group, it was 5.5 h (Fig. 4D Left) . This result indicated that down-regulation of GR-LACS mRNA in Leydig cells was not caused by the increase of the mRNA degradation by hCG but rather by a change in transcriptional activity. Nuclear run-off assays demonstrated that newly synthesized GR-LACS 32 Plabeled Leydig cell mRNA from hCG-treated animals was significantly decreased when compared with nontreated controls, whereas ␤-actin remained unchanged (Fig. 4D Right) .
Localization and Functional Analyses of GR-LACS Protein Expressed in
Transfected Cells. Subcellular localization of transfected GR-LACS tagged with GFP (GR-LACS-GFP) in mLTC and COS-1 cells by confocal microscopy demonstrated that it was localized exclusively in the cytoplasm of both cell lines (Fig. 5 A and C) , whereas GFP (control) was present throughout the nuclei, membranes, and cytoplasm ( Fig. 5 B and D) . The specificity and expression of GR-LACS-GFP were assessed by Western blotting (Fig. 5E) . A single 106-kDa band corresponding to the GR-LACS-GFP fusion protein was detected in both mLTC and COS-1 cells transfected with GR-LACS-GFP, whereas a 27-kDa GFP band was detected in GFP-transfected cells.
GR-LACS transfection increased myristoyl-CoA (14:0), palmitoyl-CoA (16:0), oleoyl-CoA (18:1), arachidonyl-CoA (20:4), and eicosapentanoyl-CoA (20:5) synthetase activities up to 2-fold over basal activity (P Ͻ 0.01). A gradual increase in basal activity was observed with the increasing chain length from C:14 to C:18 (Fig. 5F ). No differences in decanoyl-CoA (10:0) synthetase activities were observed between extracts from basal (pBK) and pBK-GR-LACS-transfected cells. Minimal endogenous lignoceroyl-CoA (24:0) synthetase activity was observed in pBK-transfected COS-1 cells, and GR-LACS-pBK transfection failed to confer additional activity. These data demonstrate that GR-LACS has acyl-CoA synthetase activity for saturated and unsaturated long chain fatty acids but displays no activity for the very long chain fatty acid (lignoceric acid, C24:0) and a medium chain fatty acid (decanoic acid, C10:0).
Discussion
This study has identified and characterized a previously uncharacterized gene termed GR-LACS that possesses structural and functional characteristics of FACS and is transcriptionally down-regulated by gonadotropin in Leydig cells of the rat testis. Although GR-LACS shares low overall amino acid sequence similarity (23-28%) with other members of the LACS (9 -11) and luciferase families (22, 23) , it contains the two conserved functional motifs that are common to these and related enzymes. One of the regions conserved in GR-LACS, LACSs (9 -11), and luciferases (22, 23) is the putative domain for the ATP-dependent covalent binding of AMP during the first reaction. The other domain is the 25-aa consensus sequence present in all FACSs; it is recognized as the FACS signature motif [1-DGWLHTGDIGXWXPXGXLKI-IDRKK25] (24). This region of GR-LACS contains 13 identical and 2 highly conserved amino acids. A single conserved substitution (E for D) is present at amino acid 1 of the invariant amino acid region (amino acids 1-8) of this motif. This conservative substitution is also present in firef ly luciferase (22, 23) . Furthermore, amino acids 16, 20, and 23 (G, I, and R), which are important for enzymatic activity, are invariant in GR-LACS. The presence in this protein of a putative AMP͞ ATP-binding domain of the family of adenylate-forming enzymes, the FACS signature motif and the functional expression of activities for long chain fatty acids demonstrate that GR-LACS is a distinct member of the FACS family.
GR-LACS mRNA is highly expressed in Leydig cells of the pubertal and adult testis and to a lesser extent in the germinal and Sertoli cells. GR-LACS mRNA was also present in the ovary and brain. Immunoreactive GR-LACS protein was expressed abundantly in the Leydig cell and minimally in the seminiferous tubule and was not detected in other tissues. The lack of expression of GR-LACS protein at sites where its mRNA is present could result from either the presence of very low levels of this protein or lack of translation of this mRNA form. Alternatively, the protein may be an alternatively spliced variant form or the product of the use of an alternate initiationtranslation site. The fact that a single mRNA species was detected in this study does not preclude the presence of additional mRNA species within the 2.7-kb range of the isolated GR-LACS that could result from alternative splicing. There is a methionine residue (amino acid 31) within the N terminus that could provide an alternative initiation site of translation. In both cases, the protein product may not be recognizable by the specific peptide antibody to the N-terminal region of GR-LACS (amino acids [16] [17] [18] [19] [20] [21] [22] [23] [24] [25] [26] [27] [28] .
The decrease in Leydig cell GR-LACS mRNA at 12 h after hCG treatment followed the down-regulation of the steroidogenic enzymes, 3␤-hydroxysteroid dehydrogenase I (1 h) and II (4 h; ref. 2) , and 17␣-hydroxylase (3 h; ref. 6) , and was concurrent with that of 17␤-hydroxysteroid dehydrogenase (7), LH, and prolactin receptors. The down-regulation of GR-LACS mRNA was concurrent with the up-regulation of gonadotropinregulated testicular RNA helicase (GRTH), a recently isolated testicular helicase that is increased by gonadotropin treatment (8) . It is of interest that the significant decrease in mRNA levels at 12 h was not paralleled by changes in protein expression, which was reduced at 24 h of hCG treatment at the time when the mRNA was maximally reduced and recovered (i.e., at 4 days, when GR-LACS mRNA began to increase). This observation is in contrast to previous findings with steroidogenic enzymes, in which, for the most part, changes in mRNA were comparable with those of protein expression (2, 6, 7) . These results indicate that the GR-LACS protein is efficiently translated. Whether this discrepancy relates to the increased levels of the GRTH (8) remains to be determined.
The temporal profile and mode of GR-LACS gene regulation by gonadotropin (after or concurrent rather than preceding reduction) indicated that the protein product is unlikely to be a transcriptional regulator of steroidogenic enzymes and LH receptors. Confocal microscopic analysis revealed an exclusively cytoplasmic localization of the expressed protein in transfected cells. Furthermore, transfection of GR-LACS cDNA into cells did not affect the activity of cotransfected receptor and steroidogenic enzyme promoters (not shown). Thus, the available evidence indicates that the observed changes on GR-LACS do not contribute to the down-regulation of steroidogenic enzymes and receptors (2, 4, 6, 7) . The transcriptional down-regulation of GR-LACS induced by hCG may result from the direct or indirect nuclear actions of mediators of the trophic hormone stimulus that precede the phase of down-regulation. In contrast to recent findings demonstrating the regulation of the gonadotropinregulated testicular RNA helicase by androgen, our studies have excluded its participation in the regulation of GR-LACS (not shown).
FACSs play a major role in intermediary metabolism of fatty acid pathways by catalyzing the activation of fatty acyl-CoA thioesters. These enzymes have a central role in cellular homeostasis through their formation of fatty acyl-CoA products that are substrates for ␤-oxidation and phospholipid biosynthesis. They are also involved in protein transport, enzyme activation, protein acylation, cell signaling, and transcriptional regulation (25, 26) . Long chain fatty acids (C12-C20) are activated by LACSs present in the mitochondria and peroxisomes where they undergo ␤-oxidation and in the microsomes where they are used in the synthesis of complex lipids. GR-LACS displayed enzymatic activity for long chain fatty acids and was shown not to possess very long chain fatty acid activity (ϾC20) in transfected COS cells.
The mRNA of the GR-LACS gene and its protein, which are down-regulated by gonadotropin, are highly expressed in Leydig cells of pubertal and adult animals. In these cells, androgen biosynthesis is active, depends highly upon the availability of steroid precursors, and has a high energy requirement. Both of these requirements may be contributed by the acyl-CoA synthetase activity of GR-LACS. In the Leydig cell, cholesterol is generated from endogenous precursors rather than derived from circulating lipoproteins, which is the case in other steroidogenic tissues (27) . For this reason, GR-LACS potentially could be of importance in the maintenance of adequate cholesterol pools required for steroid biosynthesis in the testis. It is clear that the reduction of GR-LACS gene expression induced by hCG (2.5 g) does not affect the endogenous accumulation of pregnenolone (3), indicating the adequate availability of endogenous cholesterol for pregnenolone formation in the Leydig cell during downregulation. The previously observed reduction of testosterone production by this hCG-treatment dose seems to result from the reduced transcription of enzymes distal to pregnenolone formation (2, 3, 6, 7) .
These studies have identified and characterized a form of acyl-CoA synthetase that is gonadotropin-regulated in the Leydig cell and displays preferential activity for long chain fatty acids. This form of LACS is distinct from other reported LACS enzymes expressed in the rat brain, liver, adrenal glands, and gonads (20-30% aa identity; refs. 9, 10, 12 and 13). This previously uncharacterized LACS protein may exert multiple actions at specific cellular sites through its acyl-CoA intermediates to fulfill steroidogenic and other functional requirements of testicular Leydig cells.
